J0893
HCPCSInj, decitabine (sun pharma)
Official HCPCS Level II long descriptor
Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mg
HCPCS Level II code J0893 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj, decitabine (sun pharma)
Added to HCPCS: 2023-01-01
Nearby codes in J0
- J0883Argatroban nonesrd use 1mg
- J0884Argatroban esrd dialysis 1mg
- J0885Epoetin alfa, non-esrd
- J0887Epoetin beta esrd use
- J0888Epoetin beta non esrd
- J0890Peginesatide injection
- J0891Argatroban nonesrd (accord)
- J0892Argatroban dialysis (accord)
- J0894Decitabine injection
- J0895Deferoxamine mesylate inj
- J0896Inj luspatercept-aamt 0.25mg
- J0897Denosumab injection
- J0898Argatroban nonesrd (auromed)
- J0899Argatroban dialysis, auromed
- J0901Vadadustat oral 1mg for esrd
- J0911Inst tauro 1.35mg/hep 100u
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.